A clinician’s prescription and a licensed dispensing pharmacy are essential parts of evaluating a compounded tirzepatide offer. They do not by themselves establish that the preparation meets every applicable federal and state compounding condition. FDA puts it plainly. Patients should get a prescription from their doctor and fill it at a state-licensed pharmacy [1]. Everything below is about doing that well. If you want the drug basics first, start with our compounded tirzepatide guide.
Every legal route runs through a prescriber and a licensed pharmacy
There's no legal way to buy tirzepatide without a prescription in the U.S. That's true for the brand pens and vials, and it's true for compounded versions. Compounded drugs are not FDA-approved, which means FDA doesn't review them for safety, effectiveness or quality before they're sold [1].
The rules got tighter in 2025. FDA declared the tirzepatide shortage over, and after a court denied an injunction in March 2025, the grace period for state-licensed pharmacies ended [2]. Pharmacies can still compound tirzepatide for an individual patient. The essentially-copy restriction, patient-specific significant-difference provision and enforcement discretion have different scopes; a personalized label or an individual prescription is not an automatic exemption. For the full timeline, see whether compounded tirzepatide is still available.
| Route | What you get | Prescription from | Who fills it | Offer cost or coverage | Watch for |
|---|---|---|---|---|---|
| Telehealth program, compounded | Compounded tirzepatide, usually a multi-dose vial | A clinician licensed in your state, after an online intake | The program's partner compounding pharmacy | $85–$399/mo | Whether the pharmacy is named; how billing works after month one |
| Local clinic or your own doctor, compounded | Compounded tirzepatide | Your doctor or a clinic clinician | A local or mail-order compounding pharmacy | Varies by clinic | Ask which pharmacy makes it and whether it's licensed for sterile compounding |
| LillyDirect, brand Zepbound | FDA-approved Zepbound vials or KwikPen | Any licensed prescriber | Lilly's pharmacy partners | Per 28-day supply: $299 (2.5 mg), $399 (5 mg), $449 (7.5–15 mg), eligible offer | $449 requires a refill within 45 days; otherwise $499–$699 |
| Insurance, brand Zepbound or Mounjaro | FDA-approved brand pens or vials | Your prescriber, often with prior authorization | Your retail or mail-order pharmacy | Your plan's copay | Coverage depends on the plan and the diagnosis |
Telehealth range is each program's headline monthly price for compounded tirzepatide injection, taken from each provider's own site. LillyDirect prices from Lilly's self-pay page.
Route 1: a telehealth program does the intake, the prescription and the shipping
A telehealth program is one route to a clinical assessment, not proof that every applicant receives the same product or service. A telehealth program pairs an online intake with a clinician licensed in your state and a partner pharmacy that ships to your door. Programs run $85–$399 a month as of this update.
- You fill out a health questionnaire, sometimes with photos, ID or recent labs.
- A clinician reviews it, by message or by video depending on your state's rules.
- If it's appropriate, they write a prescription for you.
- If prescribed and dispensed, confirm the pharmacy-specific shipping and storage instructions. FDA advises against using injectable GLP-1s that arrive warm or inadequately refrigerated.
- Clarify the actual follow-up schedule, response expectations and any live-visit requirements before accepting ongoing care.
Laboratory requirements and charges vary by clinical assessment and offer. Ask who orders tests, whether outside results are accepted and which fees remain payable if no prescription is issued. With confirmed 28-day billing and a charge at enrollment, 14 payments fall within the first 365 days; a four-week supply alone does not establish that charge schedule. Annualized monthly equivalents differ from actual cash due. The tirzepatide cost guide explains those comparisons.
Route 2: your own doctor or a local clinic can prescribe it too
You don't need a telehealth company. A primary care doctor, an obesity specialist or a weight-loss clinic can prescribe compounded tirzepatide and send it to a compounding pharmacy. The clinician must determine whether the preparation is clinically appropriate and meets applicable requirements; the route does not guarantee a compounded prescription.
If a clinic or med spa supplies the drug itself, ask where it comes from. A 2026 secret-shopper study of 75 weight-loss clinics and med spas in West Virginia and Oklahoma identified 23 compounding facilities as suppliers. Of the 21 it could check, 4 weren't licensed for sterile compounding, and 3 of 22 had faced state disciplinary action since 2023 [6]. More than half of those businesses (56%) sold GLP-1s mixed with B vitamins.
Route 3: brand Zepbound through LillyDirect is the non-compounded option
If you'd rather have the FDA-approved product, Lilly sells Zepbound directly to self-pay patients. As of this update, LillyDirect lists vials and KwikPens at $299 per 28-day supply at 2.5 mg, $399 at 5 mg and $449 at 7.5 mg through 15 mg under the qualifying offer [4].
The $449 tier has a condition: you have to refill within 45 days. Miss that window and the regular price applies, $499 for 7.5 mg and $699 for 10 mg and up. Needles or pen needles are bought separately. And 2.5 mg is the starting dose only, which Zepbound's label says is not approved for maintenance [5]. The compounded tirzepatide vs Zepbound comparison covers what you get for the difference.
Route 4: ask the insurer about the exact covered product and indication
Confirm whether your plan covers the exact compounded preparation before paying; provider cash pricing is not evidence of insurance coverage. Brand coverage depends on your plan and your diagnosis. Zepbound is approved for weight reduction in adults with obesity or overweight plus a weight-related condition, and for moderate to severe obstructive sleep apnea in adults with obesity [5]. Mounjaro carries the type 2 diabetes indications.
If you have coverage, ask your plan which of those uses it covers and whether it needs prior authorization. Some programs accept HSA or FSA cards for compounded medication, though eligibility is your plan's call.
Questions to settle before payment
Request these details before accepting the paid commitment. Published disclosures are useful, but personal assignment, terms and relevant licenses need their own checks.
- The pharmacy's name, and that it's a state-licensed compounding pharmacy.
- Who prescribes: the medical group, and that the clinician is licensed in your state.
- The real monthly price, with the billing cadence (monthly, every four weeks, or prepaid).
- What happens after month one: whether the price rises with the dose or after an intro offer.
- Cancellation terms, including refund rules on prepaid plans.
- A real screening step before any prescription is written.
Compare actual disclosures alongside a written quote. ARSYNL Rx names two possible pharmacy locations, but its product pages and general FAQ identify different clinical networks. Bionomy names pharmacy partners and Telegra in its terms, while assignment depends on the prescription and destination. Belle lists product-specific pharmacy partners and describes selection where available. None of those lists establishes your actual dispenser or independently verifies every current license. Read each complete review for the unresolved conditions.
For a scored list of these programs, see compounded tirzepatide programs, scored. How we score explains what goes into each number.
FDA's red flags for online GLP-1 sellers
FDA publishes a short list of warning signs for telehealth GLP-1 sellers [1], and its BeSafeRx pages show how to check that an online pharmacy is state-licensed [3]. Walk away if a company:
- claims the compounded drug is the same as an FDA-approved drug;
- offers deep discounts or prices that seem too good to be true;
- sends medicine that looks different from before, or arrives broken, damaged or without instructions;
- doesn't require screening and a prescription by a licensed healthcare professional;
- has no licensed healthcare professional available to answer questions after delivery;
- puts spelling errors or a wrong pharmacy address on the label;
- uses a pharmacy name on the label that you think might be fraudulent.
FDA has also seen fake labels naming pharmacies that don't exist, or real pharmacies that never made the product. When a box arrives, check the label against the pharmacy your program named, and don't use it if it arrived warm. The guide to tirzepatide left out of the fridge covers what FDA says about shipping.
Oral and sublingual offers need their own evidence
Programs may advertise drops, dissolving tablets or capsules. No oral tirzepatide is FDA-approved in the cited current sources, and the injection trials do not validate an oral preparation’s absorption, dose or clinical outcomes. Ask for formulation-specific human evidence instead of transferring a branded injection’s average result or a program’s testimonial to that product.
If you're weighing an oral version, ask the prescriber what evidence supports the form and dose. Your first dose question belongs with them too; the starting dose guide explains what Zepbound's label says.
Next step: compare programs on the four things that change your bill
If you go the compounded route, compare programs on the pharmacy, the prescriber, the monthly price at your likely dose and the cancellation terms. If you go brand, compare LillyDirect's price with your insurance copay. Either way, the compounded tirzepatide guide has the evidence and the safety picture behind the drug itself.